Trials / Completed
CompletedNCT01707615
Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use
Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Carotid Intima-media Thickness and Atherosclerotic Plaques in Clinical Use
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 287 (actual)
- Sponsor
- Jie Qiu · Academic / Other
- Sex
- All
- Age
- 43 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to investigate the antiatherogenic effect of GSPE in clinical use
Detailed description
Atherosclerotic plaques indicate the occurrence of ischemia events and how to deal with it is a difficult task for clinical physicians. Grape seed proanthocyanidin extrat (GSPE) has been reported to exert an antiatherogenic effect by inducing regression of atherosclerotic plaques in animal experimental studies. In this study, the antiatherogenic effect of GSPE has been investigated in clinical use.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | GSPE | GSPE 240 mg/day (120mg bid) |
| OTHER | lifestyle intervention | dietary modification making the total ingestion of calories into standard body weight 25 kCal in effect and an individualized home exercise program of a minimum 150 min/week of moderate-intensity physical activity |
Timeline
- Start date
- 2006-10-01
- Primary completion
- 2011-09-01
- Completion
- 2011-10-01
- First posted
- 2012-10-16
- Last updated
- 2012-10-16
Source: ClinicalTrials.gov record NCT01707615. Inclusion in this directory is not an endorsement.